Future of Pancreatic Cancer

Future of Pancreatic Cancer

Dr. Andres Gelrud, associate professor of medicine, says he’s hopeful that in the future, physicians will have the ability to provide therapy for patients with known genetic mutation that have led to pancreatitis.  Dr. Gelrud also foresees treatment that involves less invasive procedures.  


Published

March 14, 2016

Created by

The University of Chicago Medicine

Related Presenters

Gelrud

Andres Gelrud, MD

Associate Professor of Medicine

Andres Gelrud, MD, MMSc, is a clinical pancreatologist who provides care for patients with acute, recurrent acute and chronic pancreatitis, as well as treatment of complications from pancreatitis. He also has expertise in interventional ...

View full profile